1. Introduction {#sec0005}
===============

The incidence of breast metastasis from extramammary primary tumors ranges from 0.5% to 2% [@bib0005]. Malignant melanoma, leukemia and lymphoma are the most common among all malignancies that have been described as metastasizing to the breast [@bib0010]. By contrast metastasis from a renal cell carcinoma (RCC) to the breast is very rare. In line with SCARE criteria, we report a rare case of breast metastasis 9 years after nephrectomy for RCC and provide a review of the relevant literature [@bib0140].

2. Presentation of case {#sec0010}
=======================

An 82-year-old woman developed an RCC and underwent left nephrectomy for clear cell carcinoma at the Department of Urology of The Jikei University Kashiwa Hospital in 2005. She had no history of malignancy other than RCC, no breast disease and no family history of carcinoma. In October 2014, CT of the chest and abdomen performed as a regular follow-up revealed a mass of approximately 1 cm mass in the lateral portion of the right breast. The patient was referred to our department for further assessment and treatment. On clinical examination, no swelling was palpable in either breast. Mammography showed a smooth-margined, high-density mass in the upper outer quadrant of the right breast (see [Fig. 1](#fig0005){ref-type="fig"}). Breast US revealed a well-circumscribed, hypoechoic mass measuring 10 mm at the same site; this was judged to be a fibrous adenoma (see [Fig. 2](#fig0010){ref-type="fig"}). FNA of the right breast mass was performed, but the sample was inadequate because it did not contain breast duct epithelial cells. In June 2015, follow-up US revealed enlargement of the mass to 13 mm (see [Fig. 2](#fig0010){ref-type="fig"}); FNA was conducted for the second time, but the result was undeterminable for the same reason. CNB was performed to confirm the diagnosis. Histological examination resulted in diagnosis of the lesion as breast metastasis from an RCC of the clear-cell type. Contrast-enhanced MRI and contrast-enhanced CT showed a localized, well-enhanced mass at the same site, but no extensive intraductal component and no axillary lymph node metastasis (see [Fig. 3](#fig0015){ref-type="fig"}, [Fig. 4](#fig0020){ref-type="fig"}). Other imaging studies revealed no distant metastasis. Although adaptation for cryoablation was initially considered, eventually the patient underwent a partial mastectomy in November 2015. Gross pathology of the cut surface showed a yellowish-brown, well-defined tumor. Histological examination revealed solid alveolar proliferation of tumor cells with small round nuclei and abundant clear cytoplasm, compatible with clear cell type RCC metastasis (see [Fig. 5](#fig0025){ref-type="fig"}). The patient was asymptomatic and free of detectable disease at 18-month follow-up without any other treatment.Fig. 1The mammogram shows a smooth-margined, high-density mass in the upper outer quadrant of the right breast.Fig. 1Fig. 2US performed in October 2014 (top) shows a well-circumscribed, hypoechoic mass measuring 10 mm. US performed in June 2015 (bottom) shows enlargement of the mass to 13 mm.Fig. 2Fig. 3Contrast-enhanced MRI shows a localized, well-enhanced mass but no extensive intraductal component.Fig. 3Fig. 4Contrast-enhanced axial CT of the chest shows a corresponding enhanced homogeneous breast mass.Fig. 4Fig. 5Histopathological appearance of the resected specimen (hematoxylin-eosin stain). The photographs show solid alveolar proliferation of tumor cells with small round nuclei and abundant clear cytoplasm.Fig. 5

3. Discussion {#sec0015}
=============

The breast is a rare site of metastatic disease; the incidence of clinical breast metastasis from extramammary primary neoplasms ranges from 0.5 to 2.0% of all breast malignancies [@bib0005]. Metastases from renal adenocarcinoma to the lung and lymph nodes occur most frequently, followed by metastases to the bones, liver, contralateral kidney, ipsilateral adrenal, and pancreas [@bib0015], but metastasis to the breast is very rare. It has been suggested that, as a metastatic route to the breast tumor cells transit into the right ventricle from the inferior vena cava and spread to the breast after passing through the lungs in the arterial circulation. In addition, the paravertebral venous plexus route has been suggested [@bib0020].

Including the present case, only 23 cases of breast metastasis from RCC have been described in the literature (see [Table 1](#tbl0005){ref-type="table"}). The average age at onset is 67.4 years (47--82 years), and all patients have been female. Nine of these patients were diagnosed concurrently with RCC; of these, 2 also had confirmed metastasis to the lung, bone or liver. Fourteen cases developed after nephrectomy for RCC; most were detected palpable breast masses, although some recent cases were detected by imaging studies at follow-up. The average interval from nephrectomy to discover of breast metastasis was 9.0 years (2--18 years) which supports the understanding that RCC is a very slow-growing type of cancer.Table 1Characteristics of breast metastasis from renal cell carcinoma.Table 1Ref.YearAgeDuration(year)OpportunitySize(mm)OperationLNPostoperative treatmentFollow(mo)OutcomeChica [@bib0035]198047same timemassNSexcisional biopsyNS(−)55DODBrian [@bib0040]1983645massNSNSNSNSNSNSHardy [@bib0045]19877818mass60NSNSNSNSNSLesho [@bib0050]199274same timemass20mastectomy + ALND(−)NSNSNSBowditch [@bib0055]19966215MMGNSexcisional biopsyNSmedroxyprogesterone acetateNSNSHeggarty [@bib0060]199863same timemass20lumpectomy + ALND(−)interferonNSNSKannan [@bib0065]199865same timemass10lumpectomyNSNSNSNSForte [@bib0070]1999716mass100radical mastectomy(−)NSNSNSGrossklaus [@bib0075]200077same timeMMG25excisional biopsyNSNSNSNSVassalli [@bib0005]2001729mass35lumpectomyNS(−)12NEDO\'sullivan [@bib0080]200352same timebreast painNSNSNSNSNSNSGacci [@bib0085]2005793massNSlumpectomyNSinterferon10NEDSarah [@bib0090]200676same timemass11lumpectomy(−)interleukin-2 therapy3AWDAlzaraa [@bib0095]2007815mass17lumpectomy(−)(−)NSNSLee [@bib0100]200771same timemass40(−)NSinterleukin-2 therapy5AWDBortnik [@bib0105]2008552MMG6lumpectomyNS(−)21NEDDaneshbod [@bib0110]2008658mass22excisional biopsyNSNSNSNSDurai [@bib0115]200968same timemass20(−)NSchemotherapyNSNSHairulfaizi [@bib0120]2009675mass20mastectomy + ALND(+)(−)NSNSMahrous [@bib0125]2012585mass40lump excision(−)sunitinib14DODBotticelli [@bib0130]2013604MMG6lump excisionNSNSNSNSDhannoon [@bib0135]2017635MMG6lumpectomy + SLND(−)(−)3NEDPresent case2017829CT13partial mastectomy(−)(−)12NED[^1]

The diagnosis of breast metastasis, including cases originating from RCC, by imaging examination is difficult, and the results of FNA examination are often inconclusive because of the absence of breast duct epithelial cells. Therefore, it is important that histological diagnosis be determined by CNB and by other methods if the patient has a history of malignancy.

In almost all the reported cases of breast metastasis from RCC, lumpectomy or partial mastectomy was performed; only a few cases were treated by total mastectomy or axially lymph node dissection (ALND). ALND was performed in 4 cases, but only one of these showed lymph node metastasis. Axillary lymph node involvement is uncommon because in nearly all cases metastasis to the breast follows the hematogenous route. Generally, breast metastasis from any cancer is associated with a poor outcome; the mean survival of such patients is 10.9 months [@bib0005]. Therefore, minimally invasive surgery or nonsurgical ablation should be performed in accordance with the prognosis. On the other hand, a five-year survival rate after ablation in patients with metastasis of RCC has been reported as 53%, compared with 5% in cases in which ablation was not performed [@bib0025]. For that reason, aggressive resection should be considered in cases of solitary metastasis of RCC.

We considered that this case had appropriate therapeutic indications for cryoablation, a procedure that is often performed as clinical research in our hospital for small cancers of the breast [@bib0030], because the primary lesion in this case was RCC which the Japanese Ministry of Health admitted as an insurance adaption disease of cryoablation. However, we had to abandon cryoablation in accordance with the insurance. It is hoped that in the future insurance coverage will be expanded to cover therapeutic adaptation for cryoablation.

4. Conclusion {#sec0020}
=============

We reported an extremely rare case of breast metastasis from RCC. In such cases, it is important that the differential diagnosis of primary breast cancer and metastatic breast cancer be de determined by histological examination, and minimally invasive therapy should be performed in accordance with the prognosis.
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[^1]: Duration: duration until breast metastasis from nephrectomy, LN: axillary lymph node metastasis, MMG: mammography, NS: not stated, SLND: sentinel lymph node dissection, DOD: death of disease, NED: no evidence of disease, AWD: no operation for RCC and alive with disease.
